120 related articles for article (PubMed ID: 38042247)
1. IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1.
Xu Q; Zhou W; Zhou Y; Zhang X; Jiang R; Ai Z; Chen J; Ma L
Exp Cell Res; 2024 Jan; 434(1):113866. PubMed ID: 38042247
[TBL] [Abstract][Full Text] [Related]
2. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
3. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
4. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
5. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
6. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
Liu Y; Cai X; Cai Y; Chang Y
J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
[TBL] [Abstract][Full Text] [Related]
7. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression.
He Y; Xu S; Qi Y; Tian J; Xu F
J Ovarian Res; 2021 Nov; 14(1):163. PubMed ID: 34789312
[TBL] [Abstract][Full Text] [Related]
9. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
Li C; Lu K; Yang C; Du W; Liang Z
J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma.
Zuo X; Li W; Yan X; Ma T; Ren Y; Hua M; Yang H; Wu H; Zhu H
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278482
[TBL] [Abstract][Full Text] [Related]
11. CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity.
Assimon VA; Tang Y; Vargas JD; Lee GJ; Wu ZY; Lou K; Yao B; Menon MK; Pios A; Perez KC; Madriaga A; Buchowiecki PK; Rolfe M; Shawver L; Jiao X; Le Moigne R; Zhou HJ; Anderson DJ
ACS Chem Biol; 2019 Feb; 14(2):236-244. PubMed ID: 30640450
[TBL] [Abstract][Full Text] [Related]
12. A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis.
Taniue K; Oda T; Hayashi T; Okuno M; Akiyama T
EMBO Rep; 2011 Jul; 12(7):682-9. PubMed ID: 21617703
[TBL] [Abstract][Full Text] [Related]
13. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
15. Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C.
Ni J; Liang S; Shan B; Tian W; Wang H; Ren Y
Int J Mol Med; 2020 Jun; 45(6):1753-1770. PubMed ID: 32186750
[TBL] [Abstract][Full Text] [Related]
16. miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4.
Chen C; Zhang Q; Kong B
Clin Transl Oncol; 2023 Mar; 25(3):706-720. PubMed ID: 36538280
[TBL] [Abstract][Full Text] [Related]
17. Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.
Li H; Tong X; Xu Y; Wang M; Dai H; Shi T; Sun M; Chen K; Cheng X; Wei Q
Carcinogenesis; 2019 Oct; 40(10):1209-1219. PubMed ID: 31083717
[TBL] [Abstract][Full Text] [Related]
18. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
Ni J; Tian W; Liang S; Wang H; Ren Y
Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
[No Abstract] [Full Text] [Related]
19. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
20. Circ_0002577/miR-126-5p/MACC1 axis promotes endometrial carcinoma progression by regulation of proliferation, migration, invasion, and apoptosis of endometrial carcinoma cells.
Wang W; Jin W; Liu X; Zheng L
Arch Gynecol Obstet; 2022 Aug; 306(2):481-491. PubMed ID: 35103833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
